FHC, Inc., a global manufacturer of products for the neuroscience industry, is pleased to announce that F. Andrew (Andy) Haer has been named Chairman of the Board as of May 15, 2019
In his new role, Mr. Haer will be responsible for representing the interests of FHC shareholders. Mr. Haer will also support FHC as Director of Special Projects, using his 15 years of product development and promotion experience. Mr. Haer joined FHC in 2014 as the Director of Business Development and most recently served as Director of Customer Collaboration. He studied computer science at Northeastern University and has over 25 years of experience as a Windows application and driver software developer.
FHC, Inc. has served the neuroscience community for 48 years in its mission to advance cranial microTargeting worldwide. With a guiding principle of innovation through collaboration, FHC designs, manufactures, and internationally markets products that provide pioneering solutions for neuroscientists, neurologists, and neurosurgeons. FHC is headquartered in Bowdoin, Maine and operates globally with locations in Pennsylvania, South America and Europe.